Skip to main content
Cardiolite 1 mg/mL injection, powder, lyophilized, for solution by Lantheus Medical Imaging, Inc.
Cardiolite, 1 mg/mL, injection, powder, lyophilized, for solution Available on prescription only. Listed by Lantheus Medical Imaging, Inc..
Prescription only

Cardiolite

TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE

Listed by Lantheus Medical Imaging, Inc.

Strength
1 mg/mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous

What it contains

  • Tetrakis(2-methoxyisobutylisocyanide)copper(i) Tetrafluoroborate 1 mg/mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Approval route NDA — original brand approval
NDC code 11994-001
FDA application NDA019785
Package sizes listed 2
Marketed since December 1990

Other products containing Tetrakis 2 Methoxyisobutylisocyanide Copper I Tetrafluoroborate

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.